Carstens MG - Search Results

1

Immunological risk of injectable drug delivery systems.

Jiskoot W, van Schie RM, Carstens MG, Schellekens H. Jiskoot W, et al. Among authors: carstens mg. Pharm Res. 2009 Jun;26(6):1303-14. doi: 10.1007/s11095-009-9855-9. Epub 2009 Feb 27. Pharm Res. 2009. PMID: 19247815 Free article. Review.

2

Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines.

Carstens MG, Camps MG, Henriksen-Lacey M, Franken K, Ottenhoff TH, Perrie Y, Bouwstra JA, Ossendorp F, Jiskoot W. Carstens MG, et al. Vaccine. 2011 Jun 24;29(29-30):4761-70. doi: 10.1016/j.vaccine.2011.04.081. Epub 2011 May 10. Vaccine. 2011. PMID: 21565240

3

Evaluation of the high-pressure extrusion technique as a method for sizing plasmid DNA-containing cationic liposomes.

Carstens MG, van der Maaden K, van der Velden D, Ottenhoff TH, Melief CJ, Ossendorp F, Bouwstra JA, Jiskoot W. Carstens MG, et al. J Liposome Res. 2011 Dec;21(4):286-95. doi: 10.3109/08982104.2011.563364. Epub 2011 Mar 18. J Liposome Res. 2011. PMID: 21417671

4

Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: low-burst release is crucial for efficient CD8(+) T cell activation.

Silva AL, Rosalia RA, Sazak A, Carstens MG, Ossendorp F, Oostendorp J, Jiskoot W. Silva AL, et al. Among authors: carstens mg. Eur J Pharm Biopharm. 2013 Apr;83(3):338-45. doi: 10.1016/j.ejpb.2012.11.006. Epub 2012 Nov 29. Eur J Pharm Biopharm. 2013. PMID: 23201055

5

Opportunities and challenges in vaccine delivery.

Carstens MG. Carstens MG. Eur J Pharm Sci. 2009 Mar 2;36(4-5):605-8. doi: 10.1016/j.ejps.2008.11.004. Epub 2008 Nov 19. Eur J Pharm Sci. 2009. PMID: 19063966

6

Photocytotoxicity of mTHPC (temoporfin) loaded polymeric micelles mediated by lipase catalyzed degradation.

Hofman JW, Carstens MG, van Zeeland F, Helwig C, Flesch FM, Hennink WE, van Nostrum CF. Hofman JW, et al. Among authors: carstens mg. Pharm Res. 2008 Sep;25(9):2065-73. doi: 10.1007/s11095-008-9590-7. Epub 2008 Jul 3. Pharm Res. 2008. PMID: 18597164 Free PMC article.

7

A mechanistic study on the chemical and enzymatic degradation of PEG-Oligo(epsilon-caprolactone) micelles.

Carstens MG, van Nostrum CF, Verrijk R, de Leede LG, Crommelin DJ, Hennink WE. Carstens MG, et al. J Pharm Sci. 2008 Jan;97(1):506-18. doi: 10.1002/jps.21092. J Pharm Sci. 2008. PMID: 17879976

8

The effect of core composition in biodegradable oligomeric micelles as taxane formulations.

Carstens MG, de Jong PH, van Nostrum CF, Kemmink J, Verrijk R, de Leede LG, Crommelin DJ, Hennink WE. Carstens MG, et al. Eur J Pharm Biopharm. 2008 Mar;68(3):596-606. doi: 10.1016/j.ejpb.2007.08.014. Epub 2007 Sep 12. Eur J Pharm Biopharm. 2008. PMID: 17949956

9

Self-assembly of PEG-oligolactates with monodisperse hydrophobic blocks.

Carstens MG, van Nostrum CF, Ramzi A, de Leede LG, Crommelin DJ, Hennink WE. Carstens MG, et al. J Control Release. 2006 Nov 28;116(2):e40-1. doi: 10.1016/j.jconrel.2006.09.039. J Control Release. 2006. PMID: 17718960 No abstract available.

10

Poly(ethylene glycol)--oligolactates with monodisperse hydrophobic blocks: preparation, characterization, and behavior in water.

Carstens MG, van Nostrum CF, Ramzi A, Meeldijk JD, Verrijk R, de Leede LL, Crommelin DJ, Hennink WE. Carstens MG, et al. Langmuir. 2005 Nov 22;21(24):11446-54. doi: 10.1021/la051972t. Langmuir. 2005. PMID: 16285824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters